Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study

BACKGROUND: The purpose of this study was to determine the prevalence of high disease activity as measured using the Ankylosing Spondylitis Disease Activity Score (ASDAS) in ankylosing spondylitis (AS) patients who nonetheless have low Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) scor...

Descripción completa

Detalles Bibliográficos
Autores principales: Nam, Bora, Koo, Bon San, Lee, Tae-Han, Shin, Ji-Hui, Kim, Jin-Ju, Lee, Seunghun, Joo, Kyung Bin, Kim, Tae-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860220/
https://www.ncbi.nlm.nih.gov/pubmed/33541326
http://dx.doi.org/10.1186/s12891-020-03941-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860220/
https://www.ncbi.nlm.nih.gov/pubmed/33541326
http://dx.doi.org/10.1186/s12891-020-03941-8

Ejemplares similares